[Watchlist] Market Divergence Plays on Tap

[RagingBull Elite]( Trader, Headlines are saying we’re on pace for the worst September in 10 years. Makes it seem like there's only direction to be in these markets— short. But yesterday, while most traders woke up to red, Jeff Williams bagged [a big Weekend Wiretaps win.]( How? By capitalizing on [market divergence.]( See, no matter what direction the broader market is moving, there’s always something worth being long on. And that applies especially to [Penny Stock Land](—which JW hangs out in. We see lots of stuff there moving independent of the overall market. Like Onconova Therapeutics (ONTX). On Friday, JW saw that it was the #1 most active stock under $1 that day. It was up at least 15%, so it looked like [a savory opportunity to go with the momentum.]( No doubt, the stock had been beaten down by news of an unsuccessful drug trial. But it had been consolidated into a rounded-bottom formation. Investors had had time to reevaluate the stock and priced-in the failed clinical trials. And that was just enough for a breakout... Jeff proceeded to take initial profits on Monday in the pre-market. And he scaled out of the remainder just fifteen minutes after the open. Now, irregardless of what the market does over the next few days, [JW is looking for stocks to be long on.]( What specifically is he looking at right now? Alternet Systems - ALYI - Company is an electric motorcycle manufacturer - Recently announced an LOI for a new order up to $20 mil - Expects to increase its revenues from $300 mil to $500 mil - Has been on the move lately with a continuous news flow + overall EV hype - We’re buyers against $0.016 with a target of $0.05 Strategic Asset Leasing - LEAS - Entered into LOI to acquire cryptocurrency mining centers - Secures development contract with a recently launched California-based cannabis company - Caught our attention based on volume and technicals - We are long and will stay long above 0.0035 with a price target of 0.007 AcelRx Pharmaceuticals - ACRX - Company announced that its FDA-approved drug for pain-management, DSUVIA, has been to DoD’s Joint Deployment formulary - Shares are seeing a steady bid in the sessions after the announcement having travelled from $1.1s to $1.8s - No trade for us just yet, but we’re interested in all dips and consolidations over the next few days, assuming shares $1.5 or higher Want to see how JW potentially rides one of these stocks in [his next Weekend Wiretaps play](? [Check out his Weekend Wiretaps trading service here.]( RagingBull’s Most Popular Services Just Went On Sale [Trading Graph]( [Come And Get Em']( [This Chart Signals History May Repeat Itself]( By JC Parets of Chart Hunter --------------------------------------------------------------- [AMA: How Did You Breakout As A Trader?]( By Kyle Dennis of Biotech Breakouts --------------------------------------------------------------- [Tesla’s Battery Day Watchlist]( By Jeff Williams of Penny Pro --------------------------------------------------------------- [Credit Spread Options To Generate Steady Monthly Income]( By Dave Lukas of Options Profit Planner --------------------------------------------------------------- [Don’t Skip This Intermarket Analysis or You’ll Regret It]( By Jeff Bishop of Total Alpha RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from support@ragingbull.com]( [Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website,application or other service ("Services"), please review our full disclaimer located at [(disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication.